Reduced genomic tumor heterogeneity after neoadjuvat chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

Obulkasim, A, Yistra, B, Van Essen, HF et al. (11 more authors) (2016) Reduced genomic tumor heterogeneity after neoadjuvat chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. Oncotarget, 7 (28). pp. 44084-44095. ISSN 1949-2553

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2016, The Authors. This is an open access article licensed under a Creative Commons Attribution 3.0 License.
Keywords: esophageal adenocarcinoma, array CGH, prognosis, chemotherapy
Dates:
  • Published: 6 June 2016
  • Accepted: 29 April 2016
  • Published (online): 6 June 2016
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 16 Jun 2016 10:27
Last Modified: 05 Oct 2017 16:26
Published Version: http://dx.doi.org/10.18632/oncotarget.9857
Status: Published
Publisher: Impact Journals
Identification Number: https://doi.org/10.18632/oncotarget.9857

Share / Export

Statistics